Mast cell leukemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.

Surgery

The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.^[1]

References

↑ Georgin-Lavialle, S.; Lhermitte, L.; Dubreuil, P.; Chandesris, M.-O.; Hermine, O.; Damaj, G. (2012). “Mast cell leukemia”. Blood. 121 (8): 1285–1295. doi:10.1182/blood-2012-07-442400. ISSN 0006-4971.

Template:WikiDoc Sources

[Georgin-LavialleLhermitte2012-1] Georgin-Lavialle, S.; Lhermitte, L.; Dubreuil, P.; Chandesris, M.-O.; Hermine, O.; Damaj, G. (2012). “Mast cell leukemia”. Blood. 121 (8): 1285–1295. doi:10.1182/blood-2012-07-442400. ISSN 0006-4971.

[1]